These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)]. Rotthauwe HW; Kowalewski S Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596 [No Abstract] [Full Text] [Related]
3. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy]. Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070 [TBL] [Abstract][Full Text] [Related]
4. [Enzymology and myopathy. Diagnostic and genetic value of determination of platelet diphenol-oxydase activity]. Demos J; Berthelon M Arch Fr Pediatr; 1972 Oct; 29(8):793-9. PubMed ID: 4632798 [No Abstract] [Full Text] [Related]
5. [Muscle LDH isoenzymes in neuromuscular diseases and in carriers of recessive X-linked muscular dystrophy (duchenne)]. Kowalewski S; Rotthauwe HW Z Kinderheilkd; 1972; 113(1):55-70. PubMed ID: 5056500 [No Abstract] [Full Text] [Related]
7. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease]. Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669 [No Abstract] [Full Text] [Related]
9. Diphenoloxidases in various forms of myopathy which are transmitted by different genetic mechanisms. Demos JJ; Tuil DG; Katz PC Hum Genet; 1982; 61(3):185-9. PubMed ID: 6816716 [TBL] [Abstract][Full Text] [Related]
10. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy. Pacold I; Morgan J; Cohen L Clin Genet; 1975; 7(5):435-41. PubMed ID: 807447 [TBL] [Abstract][Full Text] [Related]
11. [Muscular dystrophy and its problems]. Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K Nihon Rinsho; 1968 Sep; 26(9):2184-98. PubMed ID: 5752294 [No Abstract] [Full Text] [Related]
17. Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease. Jackson CE; Strehler DA Pediatrics; 1968 Feb; 41(2):495-502. PubMed ID: 5637795 [No Abstract] [Full Text] [Related]
18. [Detection of healthy carriers of the myopathic trait in human myopathy]. Demos J Ann Genet; 1969 Sep; 12(3):191-201. PubMed ID: 5308546 [No Abstract] [Full Text] [Related]
19. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy]. Moser H; Mumenthaler M; Wiesmann U Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948 [No Abstract] [Full Text] [Related]
20. [Blood myoglobin in children with progressive muscular dystrophy and in carriers]. Calandi C; Baretti S; Pacciani G; Bagni P; Borsotti M; Tozzi P; Adami Lami C Quad Sclavo Diagn; 1984 Dec; 20(4):391-8. PubMed ID: 6537549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]